PHP
MRK icon

Parkman Healthcare Partners’s Merck MRK Stock Holding History

Parkman Healthcare Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-131,874
Closed -$10.4M – 92
2020
Q3 		$10.4M Buy
131,874
+8
+0% +$627 2.76% 7
2020
Q2 		$9.73M Sell
131,866
-94,320
-42% -$7.1M 2.74% 7
2020
Q1 		$16.6M Sell
226,186
-4,374
-2% -$344K 7.7% 1
2019
Q4 		$20M Buy
+230,560
New +$18.9M 5.78% 1

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parkman Healthcare Partners's MRK Position: Q4 2020 in Review

Parkman Healthcare Partners sold out of Merck (MRK) in Q4 2020, closing a stake of 131,874 shares — an estimated $10.4M sold.

Parkman Healthcare Partners first reported a position in MRK in Q4 2019 and held it in 4 quarters. The position peaked at $20M in Q4 2019. 2,709 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Parkman Healthcare Partners reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Parkman Healthcare Partners sold 131,874 Merck shares in Q4 2020, an estimated $10.4M.
  • Parkman Healthcare Partners first reported a position in Merck in Q4 2019 and held it in 4 quarters.
  • Parkman Healthcare Partners's Merck position peaked at $20M in Q4 2019.
  • 2,709 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Parkman Healthcare Partners's 13F filing for Q4 2020, filed 12 Feb 2021.